neolexon | 1,886 followers on LinkedIn. We develop apps for speech and language therapy. Approved as a Digital Health App, reimbursed by all health insurances. | neolexon develops digital solutions for speech and language therapy. Our apps are registered as medical devices, our aphasia app is approved as a Digital Health Application (DiGA) and is thus reimbursed by all statutory health insurances in Germany. Our aphasia app enables people with speech loss after brain damage to train independently and indefinitely at home in addition to logopedic treatment.